Overnight treatment of melanoma cells with AZD6244–TRAIL led to a more pronounced suppression of VEGFα and TGFβ1 secretion, compared with the effects induced by AZD6244 alone (Supplementary Figure S16b). This evidence concerns the gene TNFSF10 and melanoma.